NOVAREX

• Subjects: 151 women with obesity,premenopausal and non-diabetic, mean age 36.7 years, average weights 93.8±2.2kg
• Intake: XanthigenⓇ600mg
• Period: 16 weeks

Increase REE

Reduction of Body Fat

Reduction of Waist

Reduction of Visceral fat

Weight Loss

Effect of Xanthigen® on body weight in patients with non-alcoholic fatty liver disease (a) and in normal liver fat (b).
Weight decreased in both groups from 6 to 8 weeks after ingestion of Xanthigen®.

(a) Weights chnage in patients with non-alcoholic fatty liver disease

(b)Weights change in normal liver fat group

※Arrows indicate the time(weeks)when the first statistically signficant differences in weight loss between XanthigenⓇ and placebo groups (p<0.05)were noted.

Effects of XanthigenⓇ on resting energy expenditure (REE,kJ/MIN)in obese non-diabetic female voluteers with NAFLD.

• In the test for measuring resting energy expenditure(REE) consumtion, REE was significantly increased compared to the control group when XantigenⓇ 600mg was consumed.

PSO,pomegrante seed oil, BSE, brown seaweed extract; NAFLD, non-alcoholic fatty liver disease.